3-Iodobenzylguanidine
The therapeutic efficacy of Iobenguane can be decreased when used in combination with Protriptyline.
4-Hydroxybutyric Acid
The risk or severity of adverse effects can be increased when Gamma Hydroxybutyric Acid is combined with Protriptyline.
Abiraterone
The serum concentration of Protriptyline can be increased when it is combined with Abiraterone.
Advertisement
Acenocoumarol
Protriptyline may increase the anticoagulant activities of Acenocoumarol.
Acepromazine
The risk or severity of adverse effects can be increased when Protriptyline is combined with Acepromazine.
Aceprometazine
The risk or severity of adverse effects can be increased when Protriptyline is combined with Aceprometazine.
Advertisement
Acetophenazine
The risk or severity of adverse effects can be increased when Protriptyline is combined with Acetophenazine.
Afatinib
The serum concentration of Afatinib can be increased when it is combined with Protriptyline.
Albuterol
The risk or severity of adverse effects can be increased when Protriptyline is combined with Salbutamol.
Advertisement
Alfaxalone
The risk or severity of adverse effects can be increased when Protriptyline is combined with Alfaxalone.
Alfentanil
The risk or severity of adverse effects can be increased when Alfentanil is combined with Protriptyline.
Almotriptan
The risk or severity of adverse effects can be increased when Protriptyline is combined with Almotriptan.
Alogliptin
The serum concentration of Protriptyline can be increased when it is combined with Alogliptin.
Alosetron
Alosetron may increase the serotonergic activities of Protriptyline.
alpha 1-Antitrypsin
The serum concentration of Protriptyline can be increased when it is combined with Alpha-1-proteinase inhibitor.
Alpha 1-Proteinase Inhibitor, Human
The serum concentration of Protriptyline can be increased when it is combined with Alpha-1-proteinase inhibitor.
Alphaprodine
The risk or severity of adverse effects can be increased when Protriptyline is combined with Alphaprodine.
Alprazolam
The risk or severity of adverse effects can be increased when Alprazolam is combined with Protriptyline.
Altretamine
Altretamine may increase the orthostatic hypotensive activities of Protriptyline.
Amiodarone
The metabolism of Protriptyline can be decreased when combined with Amiodarone.
Amisulpride
The risk or severity of adverse effects can be increased when Protriptyline is combined with Amisulpride.
Amitriptyline
The risk or severity of adverse effects can be increased when Amitriptyline is combined with Protriptyline.
Amobarbital
The metabolism of Protriptyline can be increased when combined with Amobarbital.
Amoxapine
The risk or severity of adverse effects can be increased when Protriptyline is combined with Amoxapine.
Amphetamine
Amphetamine may increase the serotonergic activities of Protriptyline.
Amprenavir
The serum concentration of Protriptyline can be increased when it is combined with Amprenavir.
Anagrelide
Protriptyline may increase the QTc-prolonging activities of Anagrelide.
Antithrombin III
The serum concentration of Protriptyline can be increased when it is combined with Antithrombin III human.
Antithrombin III, Human
The serum concentration of Protriptyline can be increased when it is combined with Antithrombin III human.
Apixaban
The serum concentration of Protriptyline can be increased when it is combined with Apixaban.
Apomorphine
Protriptyline may decrease the antihypertensive activities of Apomorphine.
Apraclonidine
Protriptyline may decrease the antihypertensive activities of Apraclonidine.
Aprotinin
The serum concentration of Protriptyline can be increased when it is combined with Aprotinin.
Arbutamine
The risk or severity of adverse effects can be increased when Protriptyline is combined with Arbutamine.
Arformoterol
The risk or severity of adverse effects can be increased when Protriptyline is combined with Arformoterol.
Argatroban
The serum concentration of Protriptyline can be increased when it is combined with Argatroban.
Argatroban Anhydrous
The serum concentration of Protriptyline can be increased when it is combined with Argatroban.
Aripiprazole
The risk or severity of adverse effects can be increased when Aripiprazole is combined with Protriptyline.
Arsenic Trioxide
Protriptyline may increase the QTc-prolonging activities of Arsenic trioxide.
Artemether
Protriptyline may increase the QTc-prolonging activities of Artemether.
Articaine
The risk or severity of adverse effects can be increased when Protriptyline is combined with Articaine.
Asenapine
Protriptyline may increase the QTc-prolonging activities of Asenapine.
Asunaprevir
The serum concentration of Protriptyline can be increased when it is combined with Asunaprevir.
Atazanavir
The serum concentration of Protriptyline can be increased when it is combined with Atazanavir.
Atomoxetine
The metabolism of Protriptyline can be decreased when combined with Atomoxetine.
Azelastine
Protriptyline may increase the central nervous system depressant (CNS depressant) activities of Azelastine.
Azithromycin
Protriptyline may increase the QTc-prolonging activities of Azithromycin.
Baclofen
The risk or severity of adverse effects can be increased when Baclofen is combined with Protriptyline.
Bambuterol
The risk or severity of adverse effects can be increased when Protriptyline is combined with Bambuterol.
Barbexaclone
The metabolism of Protriptyline can be increased when combined with Barbexaclone.
Barbital
The metabolism of Protriptyline can be increased when combined with Barbital.
Bedaquiline
Protriptyline may increase the QTc-prolonging activities of Bedaquiline.
Benazepril
The serum concentration of Protriptyline can be increased when it is combined with Benazepril.
Benoxinate
The risk or severity of adverse effects can be increased when Protriptyline is combined with Oxybuprocaine.
Benperidol
The risk or severity of adverse effects can be increased when Protriptyline is combined with Benperidol.
Benzocaine
The risk or severity of adverse effects can be increased when Protriptyline is combined with Benzocaine.
Benzphetamine
Protriptyline may decrease the antihypertensive activities of Benzphetamine.
Benzyl Alcohol
The risk or severity of adverse effects can be increased when Protriptyline is combined with Benzyl alcohol.
Betaxolol
The metabolism of Protriptyline can be decreased when combined with Betaxolol.
Bethanidine
Protriptyline may decrease the antihypertensive activities of Bethanidine.
Bitolterol
The risk or severity of adverse effects can be increased when Protriptyline is combined with Bitolterol.
Bitolterol Mesylate
The risk or severity of adverse effects can be increased when Protriptyline is combined with Bitolterol.
Bivalirudin
The serum concentration of Protriptyline can be increased when it is combined with Bivalirudin.
Boceprevir
The serum concentration of Protriptyline can be increased when it is combined with Boceprevir.
Bosutinib
The serum concentration of Bosutinib can be increased when it is combined with Protriptyline.
Bosutinib monohydrate
The serum concentration of Bosutinib can be increased when it is combined with Protriptyline.
Brentuximab Vedotin
The serum concentration of Brentuximab vedotin can be increased when it is combined with Protriptyline.
Brexpiprazole
The risk or severity of adverse effects can be increased when Protriptyline is combined with Brexpiprazole.
Brimonidine
Brimonidine may increase the central nervous system depressant (CNS depressant) activities of Protriptyline.
Bromazepam
The risk or severity of adverse effects can be increased when Bromazepam is combined with Protriptyline.
Bromocriptine
Protriptyline may decrease the antihypertensive activities of Bromocriptine.
Bromperidol
The risk or severity of adverse effects can be increased when Protriptyline is combined with Bromperidol.
Brompheniramine
The risk or severity of adverse effects can be increased when Protriptyline is combined with Brompheniramine.
Brotizolam
The risk or severity of adverse effects can be increased when Protriptyline is combined with Brotizolam.
Bupivacaine
The risk or severity of adverse effects can be increased when Protriptyline is combined with Bupivacaine.
Buprenorphine
Protriptyline may increase the central nervous system depressant (CNS depressant) activities of Buprenorphine.
Bupropion
The metabolism of Protriptyline can be decreased when combined with Bupropion.
Buspirone
The risk or severity of adverse effects can be increased when Protriptyline is combined with Buspirone.
Butabarbital
The risk or severity of adverse effects can be increased when Butabarbital is combined with Protriptyline.
Butalbital
The risk or severity of adverse effects can be increased when Butalbital is combined with Protriptyline.
Butamben
The risk or severity of adverse effects can be increased when Protriptyline is combined with Butamben.
Butobarbital
The risk or severity of adverse effects can be increased when Protriptyline is combined with Butethal.
Butorphanol
The risk or severity of adverse effects can be increased when Butorphanol is combined with Protriptyline.
Cabergoline
The risk or severity of adverse effects can be increased when Cabergoline is combined with Protriptyline.
Captopril
The serum concentration of Protriptyline can be increased when it is combined with Captopril.
Carbamazepine
The metabolism of Protriptyline can be increased when combined with Carbamazepine.
Carbinoxamine
The risk or severity of adverse effects can be increased when Protriptyline is combined with Carbinoxamine.
Cariprazine
The risk or severity of adverse effects can be increased when Protriptyline is combined with Cariprazine.
Carisoprodol
The risk or severity of adverse effects can be increased when Protriptyline is combined with Carisoprodol.
Celecoxib
The metabolism of Protriptyline can be decreased when combined with Celecoxib.
Celiprolol
The risk or severity of adverse effects can be increased when Protriptyline is combined with Celiprolol.
Ceritinib
Protriptyline may increase the QTc-prolonging activities of Ceritinib.
Cetirizine
The risk or severity of adverse effects can be increased when Cetirizine is combined with Protriptyline.
Chloral Hydrate
The risk or severity of adverse effects can be increased when Protriptyline is combined with Chloral hydrate.
Chlordiazepoxide
The risk or severity of adverse effects can be increased when Chlordiazepoxide is combined with Protriptyline.
Chlormethiazole
The risk or severity of adverse effects can be increased when Protriptyline is combined with clomethiazole.
Chlormezanone
The risk or severity of adverse effects can be increased when Protriptyline is combined with Chlormezanone.
Chloroprocaine
The risk or severity of adverse effects can be increased when Protriptyline is combined with Chloroprocaine.
Chloroquine
The metabolism of Protriptyline can be decreased when combined with Chloroquine.
Chlorpheniramine
The risk or severity of adverse effects can be increased when Protriptyline is combined with Chlorphenamine.
CHLORPHENIRAMINE POLISTIREX
The risk or severity of adverse effects can be increased when Protriptyline is combined with Chlorphenamine.
Chlorpromazine
The metabolism of Protriptyline can be decreased when combined with Chlorpromazine.
Chlorprothixene
The risk or severity of adverse effects can be increased when Protriptyline is combined with Chlorprothixene.
Chlorzoxazone
The risk or severity of adverse effects can be increased when Protriptyline is combined with Chlorzoxazone.
Cholecalciferol
The metabolism of Protriptyline can be decreased when combined with Cholecalciferol.
Cilastatin
The serum concentration of Protriptyline can be increased when it is combined with Cilastatin.
Cilazapril
The serum concentration of Protriptyline can be increased when it is combined with Cilazapril.
Cimetidine
The metabolism of Protriptyline can be decreased when combined with Cimetidine.
Cinacalcet
The serum concentration of Protriptyline can be increased when it is combined with Cinacalcet.
Ciprofloxacin
Protriptyline may increase the QTc-prolonging activities of Ciprofloxacin.
Cisapride
Protriptyline may increase the arrhythmogenic activities of Cisapride.
Citalopram
The risk or severity of adverse effects can be increased when Protriptyline is combined with Citalopram.
Clarithromycin
Protriptyline may increase the QTc-prolonging activities of Clarithromycin.
Clemastine
The metabolism of Protriptyline can be decreased when combined with Clemastine.
Clenbuterol
The risk or severity of adverse effects can be increased when Protriptyline is combined with Clenbuterol.
Clidinium
The risk or severity of adverse effects can be increased when Protriptyline is combined with Clidinium.
Clidinium bromide
The risk or severity of adverse effects can be increased when Protriptyline is combined with Clidinium.
Clobazam
The metabolism of Protriptyline can be decreased when combined with Clobazam.
Clomipramine
The risk or severity of adverse effects can be increased when Protriptyline is combined with Clomipramine.
Clonazepam
The risk or severity of adverse effects can be increased when Protriptyline is combined with Clonazepam.
Clonidine
Protriptyline may decrease the antihypertensive activities of Clonidine.
Clorazepate
The risk or severity of adverse effects can be increased when Clorazepate is combined with Protriptyline.
CLORAZEPIC ACID
The risk or severity of adverse effects can be increased when Clorazepate is combined with Protriptyline.
Clotrimazole
The metabolism of Protriptyline can be decreased when combined with Clotrimazole.
Clozapine
The metabolism of Protriptyline can be decreased when combined with Clozapine.
Cobicistat
The serum concentration of Protriptyline can be increased when it is combined with Cobicistat.
Cocaine
The metabolism of Protriptyline can be decreased when combined with Cocaine.
Codeine
The risk or severity of adverse effects can be increased when Codeine is combined with Protriptyline.
Codeine Anhydrous
The risk or severity of adverse effects can be increased when Codeine is combined with Protriptyline.
CODEINE POLISTIREX
The risk or severity of adverse effects can be increased when Codeine is combined with Protriptyline.
Colchicine
The serum concentration of Colchicine can be increased when it is combined with Protriptyline.
Crizotinib
Protriptyline may increase the QTc-prolonging activities of Crizotinib.
Curcumin
The metabolism of Protriptyline can be decreased when combined with Curcumin.
Cyamemazine
The risk or severity of adverse effects can be increased when Protriptyline is combined with Cyamemazine.
Cyclizine
The risk or severity of adverse effects can be increased when Protriptyline is combined with Cyclizine.
Cyclobenzaprine
The risk or severity of adverse effects can be increased when Protriptyline is combined with Cyclobenzaprine.
Cyproheptadine
The risk or severity of adverse effects can be increased when Protriptyline is combined with Cyproheptadine.
Dabigatran Etexilate
The serum concentration of the active metabolites of Dabigatran etexilate can be increased when Dabigatran etexilate is used in combination with Protriptyline.
Dantrolene
The risk or severity of adverse effects can be increased when Protriptyline is combined with Dantrolene.
Dapiprazole
The risk or severity of adverse effects can be increased when Protriptyline is combined with Dapiprazole.
Darifenacin
The metabolism of Protriptyline can be decreased when combined with Darifenacin.
Darunavir
The serum concentration of Protriptyline can be increased when it is combined with Darunavir.
Delavirdine
The metabolism of Protriptyline can be decreased when combined with Delavirdine.
Desflurane
The risk or severity of adverse effects can be increased when Desflurane is combined with Protriptyline.
Desipramine
The risk or severity of adverse effects can be increased when Protriptyline is combined with Desipramine.
Desloratadine
The risk or severity of adverse effects can be increased when Protriptyline is combined with Desloratadine.
Desmopressin
The risk or severity of adverse effects can be increased when Protriptyline is combined with Desmopressin.
Desvenlafaxine
The risk or severity of adverse effects can be increased when Protriptyline is combined with Desvenlafaxine.
Dexbrompheniramine
The risk or severity of adverse effects can be increased when Protriptyline is combined with Dexbrompheniramine.
Dexmedetomidine
Protriptyline may decrease the antihypertensive activities of Dexmedetomidine.
Dexmethylphenidate
The risk or severity of adverse effects can be increased when Dexmethylphenidate is combined with Protriptyline.
Dextroamphetamine
Protriptyline may increase the stimulatory activities of Dextroamphetamine.
Dextromethorphan
The risk or severity of adverse effects can be increased when Protriptyline is combined with Dextromethorphan.
Dextromoramide
The risk or severity of adverse effects can be increased when Protriptyline is combined with Dextromoramide.
Dezocine
The risk or severity of adverse effects can be increased when Protriptyline is combined with Dezocine.
Diazepam
The risk or severity of adverse effects can be increased when Diazepam is combined with Protriptyline.
Dibucaine
The risk or severity of adverse effects can be increased when Protriptyline is combined with Cinchocaine.
Dicumarol
Protriptyline may increase the anticoagulant activities of Dicoumarol.
Diethylpropion
Protriptyline may increase the stimulatory activities of Diethylpropion.
Difenoxin
The risk or severity of adverse effects can be increased when Protriptyline is combined with Difenoxin.
Dihydrocodeine
The risk or severity of adverse effects can be increased when Dihydrocodeine is combined with Protriptyline.
Dihydroergotamine
Protriptyline may decrease the antihypertensive activities of Dihydroergotamine.
Dimenhydrinate
The risk or severity of adverse effects can be increased when Protriptyline is combined with Dimenhydrinate.
Diphenhydramine
The metabolism of Protriptyline can be decreased when combined with Diphenhydramine.
Diphenoxylate
The risk or severity of adverse effects can be increased when Diphenoxylate is combined with Protriptyline.
Dipivefrin
Protriptyline may decrease the antihypertensive activities of Dipivefrin.
Disopyramide
Protriptyline may increase the QTc-prolonging activities of Disopyramide.
Dobutamine
The risk or severity of adverse effects can be increased when Protriptyline is combined with Dobutamine.
Dofetilide
Protriptyline may increase the QTc-prolonging activities of Dofetilide.
Dolasetron
Protriptyline may increase the QTc-prolonging activities of Dolasetron.
Domperidone
Protriptyline may increase the QTc-prolonging activities of Domperidone.
Dothiepin
The metabolism of Protriptyline can be decreased when combined with Dosulepin.
Doxepin
The risk or severity of adverse effects can be increased when Protriptyline is combined with Doxepin.
Doxorubicin
The serum concentration of Doxorubicin can be increased when it is combined with Protriptyline.
Doxorubicin Hydrochloride
The serum concentration of Doxorubicin can be increased when it is combined with Protriptyline.
Doxylamine
Doxylamine may increase the central nervous system depressant (CNS depressant) activities of Protriptyline.
Dronedarone
Protriptyline may increase the QTc-prolonging activities of Dronedarone.
Droperidol
Droperidol may increase the central nervous system depressant (CNS depressant) activities of Protriptyline.
Droxidopa
Protriptyline may decrease the antihypertensive activities of Droxidopa.
Duloxetine
Duloxetine may increase the serotonergic activities of Protriptyline.
Dyclonine
The risk or severity of adverse effects can be increased when Protriptyline is combined with Dyclonine.
Edoxaban
The serum concentration of Edoxaban can be increased when it is combined with Protriptyline.
Efavirenz
The risk or severity of adverse effects can be increased when Protriptyline is combined with Efavirenz.
Eletriptan
The risk or severity of adverse effects can be increased when Eletriptan is combined with Protriptyline.
Eliglustat
Protriptyline may increase the QTc-prolonging activities of Eliglustat.
Enalapril
The serum concentration of Protriptyline can be increased when it is combined with Enalapril.
Enalaprilat
The serum concentration of Protriptyline can be increased when it is combined with Enalaprilat.
Enalaprilat Anhydrous
The serum concentration of Protriptyline can be increased when it is combined with Enalaprilat.
Enflurane
The risk or severity of adverse effects can be increased when Protriptyline is combined with Enflurane.
Entacapone
The risk or severity of adverse effects can be increased when Protriptyline is combined with Entacapone.
Epinephrine
Protriptyline may decrease the antihypertensive activities of Epinephrine.
ergoloid mesylates, USP
The risk or severity of adverse effects can be increased when Protriptyline is combined with Ergoloid mesylate.
Ergonovine
The risk or severity of adverse effects can be increased when Protriptyline is combined with Ergonovine.
Ergotamine
Protriptyline may decrease the antihypertensive activities of Ergotamine.
Erythromycin
Protriptyline may increase the QTc-prolonging activities of Erythromycin.
Escitalopram
The risk or severity of adverse effects can be increased when Protriptyline is combined with Escitalopram.
Estazolam
The risk or severity of adverse effects can be increased when Estazolam is combined with Protriptyline.
Eszopiclone
The risk or severity of adverse effects can be increased when Eszopiclone is combined with Protriptyline.
Ethanol
Protriptyline may increase the central nervous system depressant (CNS depressant) activities of Ethanol.
Ethchlorvynol
The risk or severity of adverse effects can be increased when Protriptyline is combined with Ethchlorvynol.
Ethosuximide
The risk or severity of adverse effects can be increased when Protriptyline is combined with Ethosuximide.
Ethotoin
The risk or severity of adverse effects can be increased when Protriptyline is combined with Ethotoin.
Ethyl Chloride
The risk or severity of adverse effects can be increased when Protriptyline is combined with Ethyl chloride.
Ethyl Loflazepate
The risk or severity of adverse effects can be increased when Protriptyline is combined with Ethyl loflazepate.
Ethylmorphine
The risk or severity of adverse effects can be increased when Protriptyline is combined with Ethylmorphine.
Etidocaine
The risk or severity of adverse effects can be increased when Protriptyline is combined with Etidocaine.
Etifoxine
The risk or severity of adverse effects can be increased when Protriptyline is combined with Etifoxine.
Etomidate
Protriptyline may decrease the antihypertensive activities of Etomidate.
Everolimus
The serum concentration of Everolimus can be increased when it is combined with Protriptyline.
Ezogabine
The risk or severity of adverse effects can be increased when Protriptyline is combined with Ezogabine.
Felbamate
The risk or severity of adverse effects can be increased when Protriptyline is combined with Felbamate.
Fenoterol
The risk or severity of adverse effects can be increased when Protriptyline is combined with Fenoterol.
Fentanyl
The risk or severity of adverse effects can be increased when Protriptyline is combined with Fentanyl.
Fexofenadine
The risk or severity of adverse effects can be increased when Protriptyline is combined with Fexofenadine.
Fibrinolysis Inhibitor
The serum concentration of Protriptyline can be increased when it is combined with Aprotinin.
Flecainide
Protriptyline may increase the QTc-prolonging activities of Flecainide.
Flibanserin
The risk or severity of adverse effects can be increased when Protriptyline is combined with Flibanserin.
Fluindione
Protriptyline may increase the anticoagulant activities of Fluindione.
Flunarizine
The risk or severity of adverse effects can be increased when Protriptyline is combined with Flunarizine.
Flunitrazepam
The risk or severity of adverse effects can be increased when Protriptyline is combined with Flunitrazepam.
Fluoxetine
The risk or severity of adverse effects can be increased when Fluoxetine is combined with Protriptyline.
Flupenthixol
Protriptyline may increase the QTc-prolonging activities of Flupentixol.
Fluphenazine
The risk or severity of adverse effects can be increased when Fluphenazine is combined with Protriptyline.
Flurazepam
The risk or severity of adverse effects can be increased when Flurazepam is combined with Protriptyline.
Fluspirilene
The risk or severity of adverse effects can be increased when Protriptyline is combined with Fluspirilene.
Fluticasone propionate
The risk or severity of adverse effects can be increased when Protriptyline is combined with Fluticasone propionate.
Fluvoxamine
The risk or severity of adverse effects can be increased when Fluvoxamine is combined with Protriptyline.
Formoterol
The risk or severity of adverse effects can be increased when Protriptyline is combined with Formoterol.
Fosamprenavir
The serum concentration of Protriptyline can be increased when it is combined with Fosamprenavir.
Fosinopril
The serum concentration of Protriptyline can be increased when it is combined with Fosinopril.
Fosphenytoin
The risk or severity of adverse effects can be increased when Protriptyline is combined with Fosphenytoin.
Fospropofol
The risk or severity of adverse effects can be increased when Protriptyline is combined with Fospropofol.
Frovatriptan
The risk or severity of adverse effects can be increased when Protriptyline is combined with Frovatriptan.
Furazolidone
Furazolidone may increase the serotonergic activities of Protriptyline.
Gabapentin
The risk or severity of adverse effects can be increased when Gabapentin is combined with Protriptyline.
Gabapentin Enacarbil
The risk or severity of adverse effects can be increased when Protriptyline is combined with Gabapentin Enacarbil.
Gadobenate
Protriptyline may increase the QTc-prolonging activities of Gadobenic acid.
Gemifloxacin
Protriptyline may increase the QTc-prolonging activities of Gemifloxacin.
Gemifloxacin Mesylate
Protriptyline may increase the QTc-prolonging activities of Gemifloxacin.
Glutethimide
The risk or severity of adverse effects can be increased when Protriptyline is combined with Glutethimide.
Goserelin
Protriptyline may increase the QTc-prolonging activities of Goserelin.
Granisetron
Protriptyline may increase the QTc-prolonging activities of Granisetron.
Guanabenz
Protriptyline may decrease the antihypertensive activities of Guanabenz.
Guanfacine
Protriptyline may decrease the antihypertensive activities of Guanfacine.
Halazepam
The risk or severity of adverse effects can be increased when Protriptyline is combined with Halazepam.
Haloperidol
The metabolism of Protriptyline can be decreased when combined with Haloperidol.
Halothane
The risk or severity of adverse effects can be increased when Protriptyline is combined with Halothane.
Heroin
The risk or severity of adverse effects can be increased when Protriptyline is combined with Heroin.
Hexobarbital
The metabolism of Protriptyline can be increased when combined with Hexobarbital.
Hexoprenaline
The risk or severity of adverse effects can be increased when Protriptyline is combined with Hexoprenaline.
Hydrocodone
Protriptyline may increase the central nervous system depressant (CNS depressant) activities of Hydrocodone.
HYDROCODONE POLISTIREX
Protriptyline may increase the central nervous system depressant (CNS depressant) activities of Hydrocodone.
Hydromorphone
The risk or severity of adverse effects can be increased when Hydromorphone is combined with Protriptyline.
Hydroxyzine
Hydroxyzine may increase the central nervous system depressant (CNS depressant) activities of Protriptyline.
Hypoxis hemerocallidea root extract
The metabolism of Protriptyline can be increased when combined with St. John's Wort.
Ibutilide
Protriptyline may increase the QTc-prolonging activities of Ibutilide.
Iloperidone
Protriptyline may increase the QTc-prolonging activities of Iloperidone.
Imidapril
The serum concentration of Protriptyline can be increased when it is combined with Imidapril.
Imipramine
The risk or severity of adverse effects can be increased when Protriptyline is combined with Imipramine.
Indacaterol
The risk or severity of adverse effects can be increased when Protriptyline is combined with Indacaterol.
Indinavir
The serum concentration of Protriptyline can be increased when it is combined with Indinavir.
INDINAVIR ANHYDROUS
The serum concentration of Protriptyline can be increased when it is combined with Indinavir.
Iproniazid
Iproniazid may increase the serotonergic activities of Protriptyline.
Isocarboxazid
The therapeutic efficacy of Protriptyline can be increased when used in combination with Isocarboxazid.
Isoetharine
The risk or severity of adverse effects can be increased when Protriptyline is combined with Isoetarine.
Isoflurane
The risk or severity of adverse effects can be increased when Isoflurane is combined with Protriptyline.
Isoflurophate
The serum concentration of Protriptyline can be increased when it is combined with Isoflurophate.
Isometheptene
Protriptyline may increase the vasopressor activities of Isometheptene.
Isoniazid
The metabolism of Protriptyline can be decreased when combined with Isoniazid.
Isoproterenol
The risk or severity of adverse effects can be increased when Protriptyline is combined with Isoprenaline.
Ixazomib
The serum concentration of Protriptyline can be increased when it is combined with Ixazomib.
Ketamine
The risk or severity of adverse effects can be increased when Ketamine is combined with Protriptyline.
Ketazolam
The risk or severity of adverse effects can be increased when Protriptyline is combined with Ketazolam.
Ketoconazole
The metabolism of Protriptyline can be decreased when combined with Ketoconazole.
Lamotrigine
The risk or severity of adverse effects can be increased when Protriptyline is combined with Lamotrigine.
Ledipasvir
The serum concentration of Ledipasvir can be increased when it is combined with Protriptyline.
Lenvatinib
Protriptyline may increase the QTc-prolonging activities of Lenvatinib.
Lenvatinib Mesylate
Protriptyline may increase the QTc-prolonging activities of Lenvatinib.
Lepirudin
The serum concentration of Protriptyline can be increased when it is combined with Lepirudin.
Leuprolide
Protriptyline may increase the QTc-prolonging activities of Leuprolide.
Levalbuterol
The risk or severity of adverse effects can be increased when Protriptyline is combined with Levosalbutamol.
Levetiracetam
The risk or severity of adverse effects can be increased when Protriptyline is combined with Levetiracetam.
Levobupivacaine
The risk or severity of adverse effects can be increased when Protriptyline is combined with Levobupivacaine.
Levocabastine
The risk or severity of adverse effects can be increased when Protriptyline is combined with Levocabastine.
Levocetirizine
The risk or severity of adverse effects can be increased when Protriptyline is combined with Levocetirizine.
Levodopa
The risk or severity of adverse effects can be increased when Protriptyline is combined with Levodopa.
Levofloxacin
Protriptyline may increase the QTc-prolonging activities of Levofloxacin.
Levofloxacin Anhydrous
Protriptyline may increase the QTc-prolonging activities of Levofloxacin.
Levomethadyl
The risk or severity of adverse effects can be increased when Protriptyline is combined with Levomethadyl Acetate.
Levomilnacipran
The risk or severity of adverse effects can be increased when Protriptyline is combined with Levomilnacipran.
Levonordefrin
Protriptyline may decrease the antihypertensive activities of Levonordefrin.
Levorphanol
The risk or severity of adverse effects can be increased when Levorphanol is combined with Protriptyline.
Levothyroxine
Levothyroxine may increase the arrhythmogenic activities of Protriptyline.
Lidocaine
The risk or severity of adverse effects can be increased when Protriptyline is combined with Lidocaine.
Linagliptin
The serum concentration of Protriptyline can be increased when it is combined with Linagliptin.
Linezolid
Linezolid may increase the serotonergic activities of Protriptyline.
Liothyronine
Liothyronine may increase the arrhythmogenic activities of Protriptyline.
Lisdexamfetamine
Protriptyline may increase the stimulatory activities of Lisdexamfetamine.
Lisdexamfetamine Dimesylate
Protriptyline may increase the stimulatory activities of Lisdexamfetamine.
Lisinopril
The serum concentration of Protriptyline can be increased when it is combined with Lisinopril.
Lisinopril Anhydrous
The serum concentration of Protriptyline can be increased when it is combined with Lisinopril.
Lithium
Lithium may increase the neurotoxic activities of Protriptyline.
Lithium Cation
Lithium may increase the neurotoxic activities of Protriptyline.
Lofexidine
The therapeutic efficacy of Protriptyline can be increased when used in combination with Lofexidine.
Lopinavir
The metabolism of Protriptyline can be decreased when combined with Lopinavir.
Loratadine
The risk or severity of adverse effects can be increased when Protriptyline is combined with Loratadine.
Lorazepam
The risk or severity of adverse effects can be increased when Lorazepam is combined with Protriptyline.
Lorcaserin
The risk or severity of adverse effects can be increased when Protriptyline is combined with Lorcaserin.
Lormetazepam
The risk or severity of adverse effects can be increased when Protriptyline is combined with Lormetazepam.
Loxapine
The risk or severity of adverse effects can be increased when Loxapine is combined with Protriptyline.
Lumefantrine
Protriptyline may increase the QTc-prolonging activities of Lumefantrine.
Lurasidone
The risk or severity of adverse effects can be increased when Lurasidone is combined with Protriptyline.
Magnesium Sulfate
The therapeutic efficacy of Protriptyline can be increased when used in combination with Magnesium sulfate.
MAGNESIUM SULFATE ANHYDROUS
The therapeutic efficacy of Protriptyline can be increased when used in combination with Magnesium sulfate.
Manidipine
The metabolism of Protriptyline can be decreased when combined with Manidipine.
Maprotiline
The risk or severity of adverse effects can be increased when Protriptyline is combined with Maprotiline.
Meclizine
The risk or severity of adverse effects can be increased when Protriptyline is combined with Meclizine.
Melatonin
The risk or severity of adverse effects can be increased when Protriptyline is combined with Melatonin.
Meperidine
The risk or severity of adverse effects can be increased when Protriptyline is combined with Pethidine.
Mephentermine
Protriptyline may increase the vasopressor activities of Mephentermine.
Mephobarbital
The metabolism of Protriptyline can be increased when combined with Methylphenobarbital.
Mepivacaine
The risk or severity of adverse effects can be increased when Protriptyline is combined with Mepivacaine.
Meprobamate
The risk or severity of adverse effects can be increased when Meprobamate is combined with Protriptyline.
Mesoridazine
The risk or severity of adverse effects can be increased when Protriptyline is combined with Mesoridazine.
Metaproterenol
The risk or severity of adverse effects can be increased when Protriptyline is combined with Orciprenaline.
Metaraminol
Protriptyline may increase the vasopressor activities of Metaraminol.
Metaxalone
The risk or severity of adverse effects can be increased when Protriptyline is combined with Metaxalone.
Methadone
The risk or severity of adverse effects can be increased when Methadone is combined with Protriptyline.
Methadyl Acetate
The risk or severity of adverse effects can be increased when Protriptyline is combined with Methadyl Acetate.
Methamphetamine
Protriptyline may decrease the antihypertensive activities of Methamphetamine.
Methapyrilene
The risk or severity of adverse effects can be increased when Protriptyline is combined with Methapyrilene.
Methaqualone
The risk or severity of adverse effects can be increased when Protriptyline is combined with Methaqualone.
Methocarbamol
The risk or severity of adverse effects can be increased when Protriptyline is combined with Methocarbamol.
Methohexital
The metabolism of Protriptyline can be increased when combined with Methohexital.
Methotrimeprazine
Protriptyline may increase the central nervous system depressant (CNS depressant) activities of Methotrimeprazine.
Methoxamine
Protriptyline may increase the vasopressor activities of Methoxamine.
Methoxyflurane
The risk or severity of adverse effects can be increased when Protriptyline is combined with Methoxyflurane.
Methsuximide
The risk or severity of adverse effects can be increased when Protriptyline is combined with Methsuximide.
Methyldopa
Protriptyline may decrease the antihypertensive activities of Methyldopa.
METHYLDOPA ANHYDROUS
Protriptyline may decrease the antihypertensive activities of Methyldopa.
Methylene blue
Protriptyline may increase the serotonergic activities of Methylene blue.
METHYLEPHEDRINE, DL-
Protriptyline may decrease the antihypertensive activities of DL-Methylephedrine.
Methylphenidate
The risk or severity of adverse effects can be increased when Methylphenidate is combined with Protriptyline.
Metoclopramide
The risk or severity of adverse effects can be increased when Metoclopramide is combined with Protriptyline.
Metoprolol
The metabolism of Protriptyline can be decreased when combined with Metoprolol.
Metylperon
The risk or severity of adverse effects can be increased when Protriptyline is combined with Melperone.
Metyrosine
The risk or severity of adverse effects can be increased when Metyrosine is combined with Protriptyline.
Midazolam
The risk or severity of adverse effects can be increased when Midazolam is combined with Protriptyline.
Midodrine
Protriptyline may increase the vasopressor activities of Midodrine.
Midostaurin
The metabolism of Protriptyline can be decreased when combined with Midostaurin.
Mifepristone
Mifepristone may increase the QTc-prolonging activities of Protriptyline.
Milnacipran
The risk or severity of adverse effects can be increased when Protriptyline is combined with Milnacipran.
Minaprine
Minaprine may increase the serotonergic activities of Protriptyline.
Minocycline
Minocycline may increase the central nervous system depressant (CNS depressant) activities of Protriptyline.
Mirabegron
The metabolism of Protriptyline can be decreased when combined with Mirabegron.
Mirtazapine
Protriptyline may increase the central nervous system depressant (CNS depressant) activities of Mirtazapine.
Moclobemide
Moclobemide may increase the serotonergic activities of Protriptyline.
Moexipril
The serum concentration of Protriptyline can be increased when it is combined with Moexipril.
Molindone
The risk or severity of adverse effects can be increased when Protriptyline is combined with Molindone.
Morphine
The risk or severity of adverse effects can be increased when Morphine is combined with Protriptyline.
Moxifloxacin
Protriptyline may increase the QTc-prolonging activities of Moxifloxacin.
Moxonidine
The therapeutic efficacy of Moxonidine can be decreased when used in combination with Protriptyline.
N-methylephedrine
Protriptyline may decrease the antihypertensive activities of DL-Methylephedrine.
Nabilone
Nabilone may increase the central nervous system depressant (CNS depressant) activities of Protriptyline.
Nalbuphine
The risk or severity of adverse effects can be increased when Nalbuphine is combined with Protriptyline.
Naloxegol
The serum concentration of Naloxegol can be increased when it is combined with Protriptyline.
Naphazoline
Protriptyline may decrease the antihypertensive activities of Naphazoline.
Naratriptan
The risk or severity of adverse effects can be increased when Protriptyline is combined with Naratriptan.
Nefazodone
The risk or severity of adverse effects can be increased when Protriptyline is combined with Nefazodone.
Nelfinavir
The serum concentration of Protriptyline can be increased when it is combined with Nelfinavir.
Nevirapine
The metabolism of Protriptyline can be decreased when combined with Nevirapine.
Nialamide
Nialamide may increase the serotonergic activities of Protriptyline.
Nicardipine
The metabolism of Protriptyline can be decreased when combined with Nicardipine.
Nicorandil
Protriptyline may increase the hypotensive activities of Nicorandil.
Nilotinib
Protriptyline may increase the QTc-prolonging activities of Nilotinib.
Nitrazepam
The risk or severity of adverse effects can be increased when Nitrazepam is combined with Protriptyline.
Nitrous Oxide
The risk or severity of adverse effects can be increased when Nitrous oxide is combined with Protriptyline.
Nordazepam
The risk or severity of adverse effects can be increased when Protriptyline is combined with Nordazepam.
Norepinephrine
Protriptyline may decrease the antihypertensive activities of Norepinephrine.
Norflurane
The risk or severity of adverse effects can be increased when Protriptyline is combined with Norflurane.
Normethadone
The risk or severity of adverse effects can be increased when Protriptyline is combined with Normethadone.
Nortriptyline
The risk or severity of adverse effects can be increased when Protriptyline is combined with Nortriptyline.
O-PHENANTHROLINE
The serum concentration of Protriptyline can be increased when it is combined with 1,10-Phenanthroline.
Ofloxacin
Protriptyline may increase the QTc-prolonging activities of Ofloxacin.
Olanzapine
The risk or severity of adverse effects can be increased when Olanzapine is combined with Protriptyline.
Olodaterol
The risk or severity of adverse effects can be increased when Protriptyline is combined with Olodaterol.
Olopatadine
The risk or severity of adverse effects can be increased when Protriptyline is combined with Olopatadine.
Ondansetron
Protriptyline may increase the QTc-prolonging activities of Ondansetron.
Opium
The risk or severity of adverse effects can be increased when Protriptyline is combined with Opium.
Orphenadrine
Protriptyline may increase the central nervous system depressant (CNS depressant) activities of Orphenadrine.
Oxazepam
The risk or severity of adverse effects can be increased when Oxazepam is combined with Protriptyline.
Oxprenolol
The risk or severity of adverse effects can be increased when Protriptyline is combined with Oxprenolol.
Oxycodone
The risk or severity of adverse effects can be increased when Oxycodone is combined with Protriptyline.
Oxymetazoline
Protriptyline may decrease the antihypertensive activities of Oxymetazoline.
Oxymorphone
The risk or severity of adverse effects can be increased when Oxymorphone is combined with Protriptyline.
p-Hydroxyamphetamine
Protriptyline may increase the stimulatory activities of Hydroxyamphetamine.
Paliperidone
Protriptyline may decrease the antihypertensive activities of Paliperidone.
Palonosetron
Palonosetron may increase the serotonergic activities of Protriptyline.
Panobinostat
The serum concentration of Protriptyline can be increased when it is combined with Panobinostat.
Paraldehyde
Protriptyline may increase the central nervous system depressant (CNS depressant) activities of Paraldehyde.
Paregoric
The risk or severity of adverse effects can be increased when Morphine is combined with Protriptyline.
Pargyline
Pargyline may increase the serotonergic activities of Protriptyline.
Paroxetine
The risk or severity of adverse effects can be increased when Paroxetine is combined with Protriptyline.
Pazopanib
The serum concentration of Pazopanib can be increased when it is combined with Protriptyline.
Peginterferon Alfa-2b
The serum concentration of Protriptyline can be decreased when it is combined with Peginterferon alfa-2b.
Pentamidine
Protriptyline may increase the QTc-prolonging activities of Pentamidine.
Pentazocine
The risk or severity of adverse effects can be increased when Pentazocine is combined with Protriptyline.
Pentobarbital
The metabolism of Protriptyline can be increased when combined with Pentobarbital.
Perampanel
Perampanel may increase the central nervous system depressant (CNS depressant) activities of Protriptyline.
Perazine
The risk or severity of adverse effects can be increased when Protriptyline is combined with Perazine.
Perflutren
Protriptyline may increase the QTc-prolonging activities of Perflutren.
Pergolide
Protriptyline may decrease the antihypertensive activities of Pergolide.
Periciazine
The risk or severity of adverse effects can be increased when Protriptyline is combined with Propericiazine.
Perindopril
The serum concentration of Protriptyline can be increased when it is combined with Perindopril.
Perphenazine
The risk or severity of adverse effects can be increased when Perphenazine is combined with Protriptyline.
Phendimetrazine
Protriptyline may increase the vasopressor activities of Phendimetrazine.
Phenelzine
Phenelzine may increase the serotonergic activities of Protriptyline.
Phenindione
Protriptyline may increase the anticoagulant activities of Phenindione.
Phenobarbital
The metabolism of Protriptyline can be increased when combined with Phenobarbital.
Phenoxyethanol
The risk or severity of adverse effects can be increased when Protriptyline is combined with Phenoxyethanol.
Phenprocoumon
Protriptyline may increase the anticoagulant activities of Phenprocoumon.
Phentermine
Protriptyline may increase the stimulatory activities of Phentermine.
PHENTERMINE RESIN
Protriptyline may increase the stimulatory activities of Phentermine.
Phenylephrine
Protriptyline may increase the vasopressor activities of Phenylephrine.
Phenylpropanolamine
The risk or severity of adverse effects can be increased when Protriptyline is combined with Phenylpropanolamine.
Phenytoin
The risk or severity of adverse effects can be increased when Phenytoin is combined with Protriptyline.
Pimozide
Protriptyline may increase the QTc-prolonging activities of Pimozide.
Pipamperone
The risk or severity of adverse effects can be increased when Protriptyline is combined with Pipamperone.
Pipothiazine
The risk or severity of adverse effects can be increased when Protriptyline is combined with Pipotiazine.
Pirbuterol
The risk or severity of adverse effects can be increased when Protriptyline is combined with Pirbuterol.
Pirinitramide
The risk or severity of adverse effects can be increased when Protriptyline is combined with Piritramide.
Pizotyline
The risk or severity of adverse effects can be increased when Protriptyline is combined with Pizotifen.
Pomalidomide
The risk or severity of adverse effects can be increased when Protriptyline is combined with Pomalidomide.
Pramipexole
Protriptyline may increase the sedative activities of Pramipexole.
Pramoxine
The risk or severity of adverse effects can be increased when Protriptyline is combined with Pramocaine.
Prazepam
The risk or severity of adverse effects can be increased when Protriptyline is combined with Prazepam.
Pregabalin
The therapeutic efficacy of Protriptyline can be increased when used in combination with Pregabalin.
Prilocaine
The risk or severity of adverse effects can be increased when Protriptyline is combined with Prilocaine.
Primaquine
Protriptyline may increase the QTc-prolonging activities of Primaquine.
Primidone
The metabolism of Protriptyline can be increased when combined with Primidone.
Procainamide
Protriptyline may increase the QTc-prolonging activities of Procainamide.
Procaine
Procaine may increase the serotonergic activities of Protriptyline.
Procarbazine
Procarbazine may increase the serotonergic activities of Protriptyline.
Procaterol
The risk or severity of adverse effects can be increased when Protriptyline is combined with Procaterol.
Prochlorperazine
The risk or severity of adverse effects can be increased when Prochlorperazine is combined with Protriptyline.
Promazine
The metabolism of Protriptyline can be decreased when combined with Promazine.
Promethazine
The risk or severity of adverse effects can be increased when Protriptyline is combined with Promethazine.
Propafenone
Protriptyline may increase the QTc-prolonging activities of Propafenone.
Proparacaine
The risk or severity of adverse effects can be increased when Protriptyline is combined with Proparacaine.
Propofol
The risk or severity of adverse effects can be increased when Propofol is combined with Protriptyline.
Propoxyphene
The risk or severity of adverse effects can be increased when Protriptyline is combined with Dextropropoxyphene.
Prothipendyl
The risk or severity of adverse effects can be increased when Protriptyline is combined with Prothipendyl.
Pseudoephedrine
Protriptyline may decrease the antihypertensive activities of Pseudoephedrine.
Quazepam
The risk or severity of adverse effects can be increased when Quazepam is combined with Protriptyline.
Quetiapine
Protriptyline may increase the QTc-prolonging activities of Quetiapine.
Quetiapine fumarate
Protriptyline may increase the QTc-prolonging activities of Quetiapine.
Quinapril
The serum concentration of Protriptyline can be increased when it is combined with Quinapril.
Quinidine
Protriptyline may increase the QTc-prolonging activities of Quinidine.
Quinine
Protriptyline may increase the QTc-prolonging activities of Quinine.
Racecadotril
The serum concentration of Protriptyline can be increased when it is combined with Racecadotril.
Racepinephrine
Protriptyline may decrease the antihypertensive activities of Racepinephrine.
Ramelteon
The risk or severity of adverse effects can be increased when Protriptyline is combined with Ramelteon.
Ramipril
The serum concentration of Protriptyline can be increased when it is combined with Ramipril.
Ranolazine
The serum concentration of Ranolazine can be increased when it is combined with Protriptyline.
Rasagiline
Rasagiline may increase the serotonergic activities of Protriptyline.
Remifentanil
The risk or severity of adverse effects can be increased when Remifentanil is combined with Protriptyline.
Remoxipride
The risk or severity of adverse effects can be increased when Protriptyline is combined with Remoxipride.
Reserpine
The risk or severity of adverse effects can be increased when Reserpine is combined with Protriptyline.
Rifaximin
The serum concentration of Rifaximin can be increased when it is combined with Protriptyline.
Risperidone
Protriptyline may decrease the antihypertensive activities of Risperidone.
Ritodrine
The risk or severity of adverse effects can be increased when Protriptyline is combined with Ritodrine.
Ritonavir
The metabolism of Protriptyline can be decreased when combined with Ritonavir.
Rivaroxaban
The serum concentration of Protriptyline can be increased when it is combined with Rivaroxaban.
Rizatriptan
The risk or severity of adverse effects can be increased when Protriptyline is combined with Rizatriptan.
Rolapitant
The metabolism of Protriptyline can be decreased when combined with Rolapitant.
Ropinirole
Protriptyline may increase the sedative activities of Ropinirole.
Ropivacaine
The risk or severity of adverse effects can be increased when Protriptyline is combined with Ropivacaine.
Rotigotine
Protriptyline may increase the sedative activities of Rotigotine.
Rucaparib
The metabolism of Protriptyline can be decreased when combined with Rucaparib.
Rufinamide
The risk or severity of adverse effects can be increased when Rufinamide is combined with Protriptyline.
Salmeterol
The risk or severity of adverse effects can be increased when Protriptyline is combined with Salmeterol.
Saquinavir
The serum concentration of Protriptyline can be increased when it is combined with Saquinavir.
Saquinavir Mesylate
The serum concentration of Protriptyline can be increased when it is combined with Saquinavir.
Saxagliptin
The serum concentration of Protriptyline can be increased when it is combined with Saxagliptin.
Saxagliptin Anhydrous
The serum concentration of Protriptyline can be increased when it is combined with Saxagliptin.
Scopolamine
The risk or severity of adverse effects can be increased when Protriptyline is combined with Scopolamine.
Scopolamine Hydrobromide
The risk or severity of adverse effects can be increased when Protriptyline is combined with Scopolamine.
Secobarbital
The metabolism of Protriptyline can be increased when combined with Secobarbital.
Selegiline
Selegiline may increase the serotonergic activities of Protriptyline.
Sertindole
The risk or severity of adverse effects can be increased when Protriptyline is combined with Sertindole.
Sertraline
The risk or severity of adverse effects can be increased when Sertraline is combined with Protriptyline.
Sevoflurane
The risk or severity of adverse effects can be increased when Sevoflurane is combined with Protriptyline.
Silodosin
The serum concentration of Silodosin can be increased when it is combined with Protriptyline.
Simeprevir
The serum concentration of Protriptyline can be increased when it is combined with Simeprevir.
Sitagliptin
The serum concentration of Protriptyline can be increased when it is combined with Sitagliptin.
Sitagliptin Phosphate
The serum concentration of Protriptyline can be increased when it is combined with Sitagliptin.
Sodium Oxybate
Sodium oxybate may increase the central nervous system depressant (CNS depressant) activities of Protriptyline.
Sodium Phosphate
The risk or severity of adverse effects can be increased when Protriptyline is combined with Sodium phosphate.
Sodium Phosphate, Monobasic
The risk or severity of adverse effects can be increased when Protriptyline is combined with Sodium phosphate.
SODIUM PHOSPHATE, MONOBASIC, ANHYDROUS
The risk or severity of adverse effects can be increased when Protriptyline is combined with Sodium phosphate.
Sotalol
Protriptyline may increase the QTc-prolonging activities of Sotalol.
Spirapril
The serum concentration of Protriptyline can be increased when it is combined with Spirapril.
ST. JOHN'S WORT EXTRACT
The metabolism of Protriptyline can be increased when combined with St. John's Wort.
Sufentanil
The risk or severity of adverse effects can be increased when Sufentanil is combined with Protriptyline.
Sulfisoxazole
Protriptyline may increase the QTc-prolonging activities of Sulfisoxazole.
Sulpiride
The risk or severity of adverse effects can be increased when Protriptyline is combined with Sulpiride.
Sumatriptan
The risk or severity of adverse effects can be increased when Protriptyline is combined with Sumatriptan.
Sumatriptan Succinate
The risk or severity of adverse effects can be increased when Protriptyline is combined with Sumatriptan.
Suvorexant
Protriptyline may increase the central nervous system depressant (CNS depressant) activities of Suvorexant.
Tapentadol
Tapentadol may increase the central nervous system depressant (CNS depressant) activities of Protriptyline.
Tasimelteon
The risk or severity of adverse effects can be increased when Protriptyline is combined with Tasimelteon.
Tedizolid
Tedizolid Phosphate may increase the serotonergic activities of Protriptyline.
Tedizolid Phosphate
Tedizolid Phosphate may increase the serotonergic activities of Protriptyline.
Telaprevir
The serum concentration of Protriptyline can be increased when it is combined with Telaprevir.
Telavancin
Protriptyline may increase the QTc-prolonging activities of Telavancin.
Telithromycin
Protriptyline may increase the QTc-prolonging activities of Telithromycin.
Temazepam
The risk or severity of adverse effects can be increased when Temazepam is combined with Protriptyline.
Terbinafine
The metabolism of Protriptyline can be decreased when combined with Terbinafine.
Terbutaline
The risk or severity of adverse effects can be increased when Protriptyline is combined with Terbutaline.
Terbutaline Sulfate
The risk or severity of adverse effects can be increased when Protriptyline is combined with Terbutaline.
Tetrabenazine
Protriptyline may increase the QTc-prolonging activities of Tetrabenazine.
Tetracaine
The risk or severity of adverse effects can be increased when Protriptyline is combined with Tetracaine.
Tetracaine hydrochloride
The risk or severity of adverse effects can be increased when Protriptyline is combined with Tetracaine.
Tetrahydrocannabinol
Dronabinol may increase the central nervous system depressant (CNS depressant) activities of Protriptyline.
Tetrahydrozoline
Protriptyline may increase the vasopressor activities of Tetryzoline.
Thalidomide
Protriptyline may increase the central nervous system depressant (CNS depressant) activities of Thalidomide.
Thiamylal
The metabolism of Protriptyline can be increased when combined with Thiamylal.
Thiopental
The metabolism of Protriptyline can be increased when combined with Thiopental.
Thiopental Sodium
The metabolism of Protriptyline can be increased when combined with Thiopental.
Thioproperazine
The risk or severity of adverse effects can be increased when Protriptyline is combined with Thioproperazine.
Thioridazine
The metabolism of Protriptyline can be decreased when combined with Thioridazine.
Thiothixene
The risk or severity of adverse effects can be increased when Thiothixene is combined with Protriptyline.
Thyroid, Porcine
Thyroid, porcine may increase the arrhythmogenic activities of Protriptyline.
Tiagabine
The risk or severity of adverse effects can be increased when Protriptyline is combined with Tiagabine.
Tiapride
The risk or severity of adverse effects can be increased when Protriptyline is combined with Tiapride.
Ticlopidine
The metabolism of Protriptyline can be decreased when combined with Ticlopidine.
Tipranavir
The metabolism of Protriptyline can be decreased when combined with Tipranavir.
Tizanidine
Protriptyline may decrease the antihypertensive activities of Tizanidine.
Tolcapone
The risk or severity of adverse effects can be increased when Tolcapone is combined with Protriptyline.
Toloxatone
Toloxatone may increase the serotonergic activities of Protriptyline.
Topiramate
The risk or severity of adverse effects can be increased when Topiramate is combined with Protriptyline.
Topotecan
The serum concentration of Topotecan can be increased when it is combined with Protriptyline.
Toremifene
Protriptyline may increase the QTc-prolonging activities of Toremifene.
Tramadol
Protriptyline may increase the neuroexcitatory activities of Tramadol.
Trandolapril
The serum concentration of Protriptyline can be increased when it is combined with Trandolapril.
Tranylcypromine
Tranylcypromine may increase the serotonergic activities of Protriptyline.
Trazodone
The risk or severity of adverse effects can be increased when Trazodone is combined with Protriptyline.
Triazolam
The risk or severity of adverse effects can be increased when Triazolam is combined with Protriptyline.
Triazulenone
The risk or severity of adverse effects can be increased when Protriptyline is combined with Loprazolam.
Trifluoperazine
The risk or severity of adverse effects can be increased when Trifluoperazine is combined with Protriptyline.
Triflupromazine
The risk or severity of adverse effects can be increased when Protriptyline is combined with Triflupromazine.
Trimipramine
The risk or severity of adverse effects can be increased when Protriptyline is combined with Trimipramine.
Triprolidine
The risk or severity of adverse effects can be increased when Protriptyline is combined with Triprolidine.
Tropisetron
Tropisetron may increase the serotonergic activities of Protriptyline.
Tryptophan
L-Tryptophan may increase the serotonergic activities of Protriptyline.
Urethane
The risk or severity of adverse effects can be increased when Protriptyline is combined with Ethyl carbamate.
Valproate
The serum concentration of Protriptyline can be increased when it is combined with Valproic Acid.
Valproic Acid
The serum concentration of Protriptyline can be increased when it is combined with Valproic Acid.
Vandetanib
Protriptyline may increase the QTc-prolonging activities of Vandetanib.
Vemurafenib
The risk or severity of QTc prolongation can be increased when Vemurafenib is combined with Protriptyline.
Venlafaxine
The risk or severity of adverse effects can be increased when Venlafaxine is combined with Protriptyline.
Vigabatrin
The risk or severity of adverse effects can be increased when Protriptyline is combined with Vigabatrin.
Vilanterol
The risk or severity of adverse effects can be increased when Protriptyline is combined with Vilanterol.
Vilazodone
The risk or severity of adverse effects can be increased when Vilazodone is combined with Protriptyline.
Vildagliptin
The serum concentration of Protriptyline can be increased when it is combined with Vildagliptin.
Vincristine
The excretion of Vincristine can be decreased when combined with Protriptyline.
Vortioxetine
The risk or severity of adverse effects can be increased when Vortioxetine is combined with Protriptyline.
Warfarin
Protriptyline may increase the anticoagulant activities of Warfarin.
Xylazine
Protriptyline may decrease the antihypertensive activities of Xylazine.
Xylometazoline
Protriptyline may decrease the antihypertensive activities of Xylometazoline.
Yohimbine
The serum concentration of Yohimbine can be increased when it is combined with Protriptyline.
Zaleplon
The risk or severity of adverse effects can be increased when Zaleplon is combined with Protriptyline.
Ziconotide
The risk or severity of adverse effects can be increased when Protriptyline is combined with Ziconotide.
Ziprasidone
Protriptyline may increase the QTc-prolonging activities of Ziprasidone.
Zofenopril
The serum concentration of Protriptyline can be increased when it is combined with Zofenopril.
Zolmitriptan
The risk or severity of adverse effects can be increased when Zolmitriptan is combined with Protriptyline.
Zolpidem
Protriptyline may increase the central nervous system depressant (CNS depressant) activities of Zolpidem.
Zonisamide
The risk or severity of adverse effects can be increased when Protriptyline is combined with Zonisamide.
Zopiclone
The risk or severity of adverse effects can be increased when Zopiclone is combined with Protriptyline.
Zotepine
The risk or severity of adverse effects can be increased when Protriptyline is combined with Zotepine.
Zuclopenthixol
Protriptyline may increase the QTc-prolonging activities of Zuclopenthixol.
